Welcome to our dedicated page for Afya SEC filings (Ticker: AFYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Afya Limited (AFYA) is a foreign private issuer that reports to the U.S. Securities and Exchange Commission primarily through Form 20‑F and Form 6‑K. This SEC filings page centralizes access to those documents, which provide detailed information on the company’s operations as a medical education group and medical practice solutions provider in Brazil.
Afya’s Form 20‑F annual report contains audited financial statements and extensive narrative disclosures on its three reportable segments: Undergraduate, Continuing Education and Medical Practice Solutions. Investors can review segment definitions, revenue composition, key operational metrics and risk factors related to its physician‑centric ecosystem and Brazilian regulatory environment.
Throughout the year, Afya files multiple Form 6‑K reports. These include unaudited interim condensed consolidated financial statements, press releases announcing quarterly and half‑year financial results, and disclosures on specific corporate events. Examples documented in recent 6‑Ks include new share repurchase programs for Class A common shares, issuance of commercial notes by Afya Participações S.A., repayment of debentures, repurchase and cancellation of Series A perpetual convertible preferred shares, changes to the board of directors, results of the annual general meeting and the engagement of a new independent registered public accounting firm.
For investors analyzing AFYA, these filings are key sources for understanding revenue trends, adjusted EBITDA, net income, capital structure decisions and governance developments. They also provide context on Afya’s medical school seat authorizations and other regulatory milestones in Brazil’s higher education sector.
On Stock Titan, Afya’s SEC filings are updated in line with EDGAR submissions and can be paired with AI‑powered summaries that explain the main points of lengthy documents. Users can quickly identify which filings relate to financial results, capital markets transactions, governance changes or other material events, and then drill down into the full text when deeper analysis is required.
Afya Ltd vice president Gustavo De Souza Portes Meirelles reported his initial holdings in Class A Common Shares and equity awards. He holds stock options to acquire 12,000 Class A shares in each of five grants at an exercise price of 79.9100, exercisable in Brazilian Reais, with expirations ranging from May 1, 2028 to May 1, 2032. These options fully vest and become exercisable three years before their respective expiration dates, subject to continued service.
He also holds restricted stock units covering 31,500 Class A shares, which are scheduled to vest in tranches of 7,000, 10,500 and 14,000 shares on May 1, 2026, May 1, 2027 and May 1, 2028, respectively, contingent on continued service. In addition, he directly owns 2,537 Class A Common Shares.
Afya Ltd director Christina Bacon Krebs filed an initial statement of beneficial ownership on Form 3. This filing establishes her status as a reporting insider of the company. It does not list any transactions or changes in ownership, only her entry into insider reporting obligations.
Afya Ltd vice president Stella Caldeira Brant Rodrigues filed an initial ownership report showing her equity position in the company. She directly holds 39,140 Class A Common Shares as of the filing date.
She also holds stock options covering 80,000 Class A Common Shares, with exercise prices of R$62.59 and R$52.00 and expiration dates from May 1, 2027 through May 1, 2030; these options fully vest and become exercisable three years before each expiration date, subject to continued service, and the exercise prices are denominated in Brazilian reais.
In addition, she has restricted stock units over 17,600 Class A Common Shares with no expiration date that will vest on May 1, 2026, also subject to her continued service through that vesting date.
Afya Ltd director Esteves Nicolau Carvalho filed an initial ownership report showing existing stakes in the company, with no new buy or sell transactions. The filing lists indirect holdings through NRE Capital Ventures Ltd., including Class B Common Shares that are convertible into Class A Common Shares on a one-for-one basis with no expiration date.
Afya Ltd director Renato Tavares Esteves filed an initial ownership report showing indirect beneficial ownership of 1,263,613 Class A common shares. These shares are held through RTE B Ventures Ltd., which is solely owned and controlled by Esteves.
Afya Ltd’s Chief Financial Officer, Luis Andre Carpintero Blanco, has filed an initial Form 3 detailing his equity holdings. He directly holds 61,103 Class A Common Shares. He also holds stock options to buy 14,000 Class A shares in each of five grants at an exercise price of 62.5900, expiring between May 2029 and May 2033, and options on 23,500 shares in each of two grants at an exercise price of 52.0000, expiring in May 2029 and May 2030.
In addition, he holds restricted stock units covering 35,000, 3,200 and 16,800 Class A shares. According to the footnotes, these RSUs vest on May 1 of 2026, 2027, 2028 and 2029, subject to his continued service with the company.
Afya Ltd director Krafft Kay Christian filed an initial insider ownership report on Form 3. This filing establishes his status as a director and discloses that, in this report, there are no insider share purchases, sales, option exercises, gifts, or other transactions recorded.
Afya Ltd filed an initial insider ownership report for director Pereira de Paula Miguel Filisbino. This Form 3 does not report any purchases, sales, gifts, or other transactions, and it shows no derivative positions or other holdings in the sections visible in this data.
Afya Ltd director Vanessa Claro Lopes filed an initial Form 3 reporting her beneficial ownership in the company. The filing shows she directly holds 1,315 Class A common shares following the reported position. This is a registration of existing holdings rather than a new buy or sell transaction.
Afya Ltd filed a Form 3 identifying Dominik Dalkmann Benedikt Karl as a director and reporting person. The insider filing data show no reported share transactions or derivative positions, indicating this is an initial ownership statement rather than a report of buys or sells.